AzTrials
AzTrials

Coronary Artery DiseaseSTARTERSNCT06358105

Simulator Training to Improve Interventional Cardiologist Skills (STARTERS) Trial

A study testing Simulator-based training and Standard training in people with Coronary Artery Disease, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if simulator-based training will improve interventional cardiology fellows' skills and will improve patient outcomes. The main questions it aims to answer are: Does this training improve specific operative parameters recorded during initial coronary interventions performed… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Coronary Artery Disease
What is being tested?
Simulator-based training and Standard training
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteItaly
Study dates
15 Nov 2024to 15 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Specializing doctors who are about to start dedicated training in the interventional cardiology room
  • Patients who must undergo coronary angiography examination.

Who cannot join

  • Specializing doctors:
  • No interest in performing interventional cardiology procedures as first supervised operator (classical training)
  • Experience as first supervised operator in interventional cardiology procedures
  • Absence of informed consent
  • Patients:
  • Acute Coronary Syndrome
Show all 9Show fewer
  • Severe left ventricular dysfunction with ejection fraction less than 30%
  • Severe chronic renal failure (with glomerular filtration rate less than 30 ml/min)
  • Absence of informed consent

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Fondazione Policlinico Univrsitario Agostino Gemelli IRCCS

    Rome, 00168

Other trials in Italy

About this study

The goal of this clinical trial is to learn if simulator-based training will improve interventional cardiology fellows' skills and will improve patient outcomes.

The main questions it aims to answer are:

Read more
  • Does this training improve specific operative parameters recorded during initial coronary interventions performed as first operators under senior supervision?
  • Will major and minor procedural complications be reduced after simulator-based training?

Interventional cardiology fellows in their first year of training will be randomized between standard master-apprentice training or simulator-based training before starting their cath lab period.

They will be supervised during their cath lab period as first operators by senior interventional cardiologists.

During their first 50 procedures performed as supervised first operator, specific procedural data will be collected.

Being tested
Simulator-based training, Standard training
Keywords
simulation, training, fellows, coronary artery disease, coronary angiography
Medical subject headings
Coronary Artery Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Simulator-based trainingProcedure or surgery

    A two-day training program will be performed before starting their cath lab period as interventional cardiology fellows

  • Standard trainingProcedure or surgery

    Standard master-apprentice training interventional cardiology fellows' program during their cath lab period

Study groups in NCT06358105
Study groupRoleWhat they receive
Simulator-based training groupExperimentalInterventional cardiology fellows will undergo a two-day training program on high-fidelity simulators
Receives: Procedure: Simulator-based training
Standard groupActive comparatorInterventional cardiology fellows will undergo standard training based on master-apprentice model
Receives: Procedure: Standard training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean total fluoroscopy radiation time (expressed in seconds)

    Difference in Mean total fluoroscopy radiation time, during the periods where the cardiology fellows act as primary operators, between groups

    Measured: End of procedure

Secondary outcomes (8)
  1. Mean arterial cannulation time (expressed in seconds)

    Difference in mean coronary cannulation time is considered as the time from sheath insertion to first right and left selective coronary angiography obtained (expressed in minutes)

    Measured: End of procedure

  2. Total radiation dose (expressed in cGy*cm2)

    Difference in total radiation dose adsorbed by patients as evaluated by dose-area product (DAP) (expressed in Gycm2)

    Measured: End of procedure

  3. Total contrast dose (expressed in ml)

    Difference in total contrast dose administered to the patients

    Measured: End of procedure

  4. Failure to achieve arterial cannulation (e.g.: rate of failure for each partecipant)

    Difference in failure to achieve arterial cannulation

    Measured: End of procedure

  5. Failure to achieve right coronary cannulation (e.g.: rate of failure for each partecipant)

    Difference in failure to achieve right coronary cannulation

    Measured: End of procedure

  6. Failure to achieve left coronary cannulation (e.g.: rate of failure for each partecipant)

    Difference in failure to achieve left coronary cannulation

    Measured: End of procedure

  7. Number of catheters used

    Difference in number of catheters used to complete the diagnostic procedure

    Measured: End of procedure

  8. Any major or minor procedural and clinical complication

    Difference in any major or minor complication occurred during the procedure or the index hospitalization

    Measured: Up to the end of index hospitalization or date of death from any cause (we collect any kind of clinical or procedural complication occuring during the determined period)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2024
  2. Study start15 Nov 2024 (estimated)
  3. Primary completion15 Nov 2024 (estimated)
  4. Study completion15 Nov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06358105
Sponsor's protocol ID
id. 6457
Acronym
STARTERS
Status last verified
Apr 2024
First submitted
2 Apr 2024
Last updated
10 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Aggarwal S, Choudhury E, Ladha S, Kapoor PM, Kiran U. Simulation in cardiac catheterization laboratory: Need of the hour to improve the clinical skills. Ann Card Anaesth. 2016 Jul-Sep;19(3):521-6. doi: 10.4103/0971-9784.185548.

    PubMed 27397459
  • Pezel T, Coisne A, Bonnet G, Martins RP, Adjedj J, Biere L, Lattuca B, Turpeau S, Popovic B, Ivanes F, Lafitte S, Deharo JC, Bernard A. Simulation-based training in cardiology: State-of-the-art review from the French Commission of Simulation Teaching (Commission d'enseignement par simulation-COMSI) of the French Society of Cardiology. Arch Cardiovasc Dis. 2021 Jan;114(1):73-84. doi: 10.1016/j.acvd.2020.10.004. Epub 2021 Jan 5.

    PubMed 33419690
  • Sciahbasi A, Romagnoli E, Trani C, Burzotta F, Pendenza G, Tommasino A, Leone AM, Niccoli G, Porto I, Penco M, Lioy E. Evaluation of the "learning curve" for left and right radial approach during percutaneous coronary procedures. Am J Cardiol. 2011 Jul 15;108(2):185-8. doi: 10.1016/j.amjcard.2011.03.022. Epub 2011 Apr 29.

    PubMed 21530937
  • Joshi A, Wragg A. Simulator Training in Interventional Cardiology. Interv Cardiol. 2016 May;11(1):70-73. doi: 10.15420/icr.2016.11.1.70.

    PubMed 29588710
  • Popovic B, Pinelli S, Albuisson E, Metzdorf PA, Mourer B, Tran N, Camenzind E. The Simulation Training in Coronary Angiography and Its Impact on Real Life Conduct in the Catheterization Laboratory. Am J Cardiol. 2019 Apr 15;123(8):1208-1213. doi: 10.1016/j.amjcard.2019.01.032. Epub 2019 Jan 24.

    PubMed 30732853
  • Voelker W, Petri N, Tonissen C, Stork S, Birkemeyer R, Kaiser E, Oberhoff M. Does Simulation-Based Training Improve Procedural Skills of Beginners in Interventional Cardiology?--A Stratified Randomized Study. J Interv Cardiol. 2016 Feb;29(1):75-82. doi: 10.1111/joic.12257. Epub 2015 Dec 16.

    PubMed 26671629

Questions about this trial

What is this clinical trial studying?

A study testing Simulator-based training and Standard training in people with Coronary Artery Disease, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact FRANCESCO Burzotta, Prof.. (+393494295290, francesco.burzotta@policlinicogemelli.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean total fluoroscopy radiation time (expressed in seconds) (time frame: End of procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06358105, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in